Physiomics Regulatory News (PYC)

8 Jun 2006 10:03

Physiomics plc ("Physiomics" or "the Company") Resignation of Chief Executive Officer Oxford, UK 8 June 2006: The Board of Physiomics plc (AIM:PYC), a Europeansystems biology simulation company, today announces that Dr John Savin, CEO hasleft the Company and resigned as a Director.Mr David Evans, Chairman of Physiomics commented:"The need to secure a long term future for the Company on a basis differentfrom the current business model has required a detailed strategic review inconjunction with EiRx Pharma Ltd which currently controls a 69% shareholding.Dr Savin felt that this process would be easier if he were to leave the Companyon amicable terms and this has now been agreed. On behalf of the Board, I wouldlike to thank Dr Savin for his pivotal contribution to the development ofPhysiomics since 2001."Dr Savin commented"I am very sad to be leaving Physiomics having led the business from itsstart-up phase through the AIM listing and for its first 18 months as a quotedcompany. However, I am pleased that the Company is now well placed to takeadvantage of the increasing opportunities in the application of systembiology."Contact:David Evans, Chairman07740 084452ENDPHYSIOMICS PLC